anti-Biglycan (BGN) Antikörper

anti-Biglycan Antikörper (BGN)
Auf finden Sie aktuell 115 Biglycan (BGN) Antikörper von 18 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen Biglycan Kits (34) und Biglycan Proteine (29) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 186 Biglycan Produkte verfügbar.
BG, BGN, BSPG1, DKFZp468I2427, DSPG1, PG-S1, PGI, SLRR1A, xbgn, zgc:77123, zgc:91989

Meistgesuchte Reaktivitäten zu anti-Biglycan (BGN) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Human Biglycan Antikörper:

anti-Rat (Rattus) Biglycan Antikörper:

anti-Mouse (Murine) Biglycan Antikörper:

Alle verfügbaren anti-Biglycan Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Am meisten referenzierte anti-Biglycan Antikörper

  1. Human Monoclonal Biglycan Primary Antibody für WB - ABIN393299 : Yang, Burch, Getachew, Ballinger, Osman, Little: Growth factor-mediated hyper-elongation of glycosaminoglycan chains on biglycan requires transcription and translation. in Archives of physiology and biochemistry 2009 (PubMed)
    Zeige alle 5 Referenzen für 393299

  2. Human Polyclonal Biglycan Primary Antibody für IHC, IHC (p) - ABIN4284625 : Van Bockstal, Lambein, Van Gele, De Vlieghere, Limame, Braems, Van den Broecke, Cocquyt, Denys, Bracke, Libbrecht, De Wever: Differential regulation of extracellular matrix protein expression in carcinoma-associated fibroblasts by TGF-β1 regulates cancer cell spreading but not adhesion. in Oncoscience 2015 (PubMed)
    Zeige alle 2 Referenzen für 4284625

  3. Human Polyclonal Biglycan Primary Antibody für IHC, ELISA - ABIN334359 : Chen, Lenschow, Tiede, Fischer, Kalthoff, Ungefroren: Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells. in The Journal of biological chemistry 2002 (PubMed)
    Zeige alle 2 Referenzen für 334359

  4. Human Polyclonal Biglycan Primary Antibody für IF (p), IHC (p) - ABIN872817 : Huang, Zou, Shi, Zhang, Pen, Zhang, Gao, Wang: The effect of electroacupuncture on the extracellular matrix synthesis and degradation in a rabbit model of disc degeneration. in Evidence-based complementary and alternative medicine : eCAM 2014 (PubMed)
    Zeige alle 2 Referenzen für 872817

  5. Human Polyclonal Biglycan Primary Antibody für EIA, IHC (p) - ABIN452781 : Sardo, Mandraffino, Campo, Saitta, Bitto, Alibrandi, Riggio, Imbalzano, Saitta: Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness. in Clinica chimica acta; international journal of clinical chemistry 2009 (PubMed)
    Zeige alle 2 Referenzen für 452781

  6. Cow (Bovine) Polyclonal Biglycan Primary Antibody für WB - ABIN2786644 : Gogiel, Galewska, Romanowicz, Jaworski, Bańkowski: Pre-eclampsia-associated alterations in decorin, biglycan and versican of the umbilical cord vein wall. in European journal of obstetrics, gynecology, and reproductive biology 2007 (PubMed)

  7. Human Polyclonal Biglycan Primary Antibody für FACS, IHC (p) - ABIN390701 : Traupe, van den Ouweland, van Oost, Vogel, Vetter, Warren, Rocchi, Darlison, Ropers: Fine mapping of the human biglycan (BGN) gene within the Xq28 region employing a hybrid cell panel. in Genomics 1992 (PubMed)

  8. Human Monoclonal Biglycan Primary Antibody für IHC (p), IP - ABIN560056 : Zhang, Lee, Young, Wang: The Small Leucine-Rich Proteoglycan BGN Accumulates in CADASIL and Binds to NOTCH3. in Translational stroke research 2015 (PubMed)

Weitere Antikörper gegen Biglycan Interaktionspartner

Human Biglycan (BGN) Interaktionspartner

  1. study reports a temporal relationship between altered placental biglycan expression and subsequent development of fetal growth restriction/small for gestational age.

  2. Quantitative polymerase chain reaction for messenger RNA expression from tissue specimens revealed significantly higher expression of Biglycan (p = 0.0008) and Lumican (zeige LUM Antikörper) (p = 0.01) and lower expression of Decorin (zeige DCN Antikörper) (p < 0.0001) in urothelial carcinoma of bladder

  3. Mutation in BGN gene is associated with X-Linked Spondyloepimetaphyseal Dysplasia.

  4. biglycan exerts an important role in cell proliferation, migration, invasion and apoptosis in colon cancer.

  5. BGN might play an important role on metastasis in human endometrial cancer and it might be a target marker for the molecular therapy of advanced and recurrence endometrial cancer.

  6. This study demonstrated that the small leucine-rich proteoglycan (zeige Vcan Antikörper) BGN accumulates in CADASIL (zeige NOTCH3 Antikörper) and binds to NOTCH3 (zeige NOTCH3 Antikörper).

  7. Biglycan may have a role in development of vascular damage in smokers

  8. BGN is a factor secreted by peritubular cells to modulate FGFR3c signaling and thus contributes to the regulation of spermatogonial maintenance

  9. The results suggest that regions within BGN is associated with ACL (zeige ACLY Antikörper) injury susceptibility and that genetic sequence variability within genes encoding proteoglycans may potentially modulate the ligament fibril properties.

  10. immunolocalization of decorin (zeige DCN Antikörper) and biglycan in samples of first-trimester and term placentas, placenta accreta, invasive mole, and choriocarcinoma

Mouse (Murine) Biglycan (BGN) Interaktionspartner

  1. Biglycan plays a protective role during the progression of atherosclerosis in ApoE (zeige APOE Antikörper)-deficient mice by inhibiting thrombin (zeige F2 Antikörper) generation.

  2. These genes were concordantly induced by TAC (zeige IL2RA Antikörper) in WT but not in biglycan KO mice. CONCLUSIONS: Left ventricular pressure overload induces biglycan expression in cardiac fibroblasts. Ablation of biglycan improves cardiac function and attenuates left ventricular hypertrophy and fibrosis after long-term pressure overload.

  3. Importance of biglycan and decorin (zeige DCN Antikörper) as targets for the manipulation of fetal membrane extracellular matrix stability in the context of inflammation.

  4. Biglycan deficiency leads to loosely packed aortic collagen fibers, increased susceptibility of aortic elastin (zeige ELN Antikörper) fibers to angII-induced stress, and up-regulation of vascular perlecan (zeige HSPG2 Antikörper) content.

  5. Biglycan signaling supported fetal membrane remodeling during early gestation in the absence of concomitant changes in TGFbeta (zeige TGFB1 Antikörper) levels.

  6. Lumican (zeige LUM Antikörper) and biglycan influence corneal keratocyte lamellipodia organization and are critical in the regulation of stromal collagen fibrillogenesis.

  7. Biglycan-triggered TLR-2 (zeige TLR2 Antikörper)- and TLR-4 (zeige TLR4 Antikörper)-signaling exacerbates the pathophysiology of ischemic acute kidney injury.

  8. De novo expression of circulating biglycan evokes an innate inflammatory tissue response via MyD88 (zeige MYD88 Antikörper)/TRIF (zeige RNF138 Antikörper) pathways.

  9. Early stage patellar tendon healing was inferior in biglycan-null and decorin (zeige DCN Antikörper)-null mice as compared to wild type.

  10. This suggests that biglycan and decorin (zeige DCN Antikörper) may have sequential roles in the tendon response to injury.

Xenopus laevis Biglycan (BGN) Interaktionspartner

  1. Bgn regulates BMP4 (zeige BMP4 Antikörper) signaling through modulation of Chordin (zeige CHRD Antikörper) anti-BMP4 (zeige BMP4 Antikörper) activity.

Pig (Porcine) Biglycan (BGN) Interaktionspartner

  1. LDL electrostatic interactions with decorin (zeige DCN Antikörper) and biglycan in the aortic valve leaflets and vascular wall is a major source of LDL retention.

Cow (Bovine) Biglycan (BGN) Interaktionspartner

  1. Data show that biglycan, collagen type I, collagen type II, decorin (zeige DCN Antikörper), and versican (zeige Vcan Antikörper) were significantly affected by vibration duration, frequency, and amplitude.

  2. biglycan showed a unique ability to organize collagen VI into extensive hexagonal-like networks over a time period of only a few minutes

  3. biglycan-induced fibroblast cytoskeletal and signalling changes result in an increased cell migration; potential role in the remodelling process

  4. The results indicate that CTGF (zeige CTGF Antikörper) suppresses the synthesis of biglycan but newly induced that of decorin (zeige DCN Antikörper) in the cells when the cell density is low.

Rabbit Biglycan (BGN) Interaktionspartner

Biglycan (BGN) Antigen-Profil

Beschreibung des Gens

The protein encoded by this gene is a small cellular or pericellular matrix proteoglycan that is closely related in structure to two other small proteoglycans, decorin and fibromodulin. The encoded protein and decorin are thought to be the result of a gene duplication. Decorin contains one attached glycosaminoglycan chain, while this protein probably contains two chains. For this reason, this protein is called biglycan. This protein plays a role in assembly of collagen fibrils and muscle regeneration. It interacts with several proteins involved in muscular dystrophy, including alpha-dystroglycan, alpha- and gamma-sarcoglycan and collagen VI, and it is critical for the assembly of the dystrophin-associated protein complex.

Alternative names and synonyms associated with Biglycan (BGN)

  • biglycan a (bgna) Antikörper
  • biglycan (BGN) Antikörper
  • biglycan (bgn) Antikörper
  • biglycan (Bgn) Antikörper
  • biglycan b (bgnb) Antikörper
  • BG Antikörper
  • BGN Antikörper
  • BSPG1 Antikörper
  • DKFZp468I2427 Antikörper
  • DSPG1 Antikörper
  • PG-S1 Antikörper
  • PGI Antikörper
  • SLRR1A Antikörper
  • xbgn Antikörper
  • zgc:77123 Antikörper
  • zgc:91989 Antikörper

Bezeichner auf Proteinebene für anti-Biglycan (BGN) Antikörper

biglycan , biglycan proteoglycan , bone/cartilage proteoglycan I , bone/cartilage proteoglycan-I , dermatan sulphate proteoglycan I , small leucine-rich protein 1A , PG-S1 , Small proteoglycan I (biglycan), bone (BSPG1) (bone/cartilage proteclycan 1 precursor) , bone/cartilage proteclycan 1 , leucine-rich PG I

431774 Danio rerio
473829 Pan troglodytes
697544 Macaca mulatta
780007 Xenopus (Silurana) tropicalis
100033861 Equus caballus
100172504 Pongo abelii
100294505 Salmo salar
100590598 Nomascus leucogenys
633 Homo sapiens
25181 Rattus norvegicus
403905 Canis lupus familiaris
12111 Mus musculus
444695 Xenopus laevis
397396 Sus scrofa
280733 Bos taurus
100008663 Oryctolagus cuniculus
100033879 Equus caballus
443011 Ovis aries
399351 Xenopus laevis
792197 Danio rerio
Ausgewählte Anbieter für anti-Biglycan (BGN) Antikörper
Haben Sie etwas anderes gesucht?